Ross, Joseph S.

The Predictive Approaches to Treatment effect Heterogeneity (PATH) statement

Kent, D. M., Paulus, J. K., van Klaveren, D., D'Agostino, R., Goodman, S., Hayward, R., Ioannidis, J. P. A., Patrick-Lake, B., Morton, S., Pencina, M., et al. (2020) · Annals of Internal Medicine

Statistical Methods in Clinical TrialsAdvanced Causal Inference Techniques

Cited by 469

Potential overtreatment of diabetes mellitus in older adults with tight glycemic control

Lipska, K. J., Ross, J. S., Miao, Y., Shah, N. D., Lee, S. J., & Steinman, M. A. (2015) · JAMA Internal Medicine

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 408

Trial Publication after Registration in ClinicalTrials.Gov: A Cross-Sectional Analysis

Ross, J. S., Mulvey, G. K., Hines, E. M., Nissen, S. E., & Krumholz, H. M. (2009) · PLoS Medicine

Pharmaceutical industry and healthcareMeta-analysis and systematic reviews

Cited by 401

Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis

Ross, J. S., Tse, T., Zarin, D. A., Xu, H., Zhou, L., & Krumholz, H. M. (2012) · BMJ

Academic Publishing and Open AccessPharmaceutical industry and healthcare

Cited by 371

Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010

Downing, N. S., Shah, N. D., Aminawung, J. A., Pease, A. M., Zeitoun, J.-D., Krumholz, H. M., & Ross, J. S. (2017) · JAMA

Pharmacovigilance and Adverse Drug ReactionsPharmaceutical Economics and Policy

Cited by 324

Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006–2013

Lipska, K. J., Yao, X., Herrin, J., McCoy, R. G., Ross, J. S., Steinman, M. A., Inzucchi, S. E., Gill, T. M., Krumholz, H. M., & Shah, N. D. (2017) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 306

What have we learnt from Vioxx?

Krumholz, H. M., Ross, J. S., Presler, A. H., & Egilman, D. S. (2007) · BMJ

Inflammatory mediators and NSAID effectsPharmacovigilance and Adverse Drug Reactions

Cited by 267

Effect of Blinded Peer Review on Abstract Acceptance

Ross, J. S., Gross, C. P., Desai, M. M., Hong, Y., Grant, A. O., Daniels, S. R., Hachinski, V. C., Gibbons, R. J., Gardner, T. J., & Krumholz, H. M. (2006) · JAMA

Academic Writing and PublishingAcademic Publishing and Open Access

Cited by 250

Publication and reporting of clinical trial results: cross sectional analysis across academic medical centers

Chen, R., Desai, N. R., Ross, J. S., Zhang, W., Chau, K. H., Wayda, B., Murugiah, K., Lu, D. Y., Mittal, A., & Krumholz, H. M. (2016) · BMJ

Pharmaceutical industry and healthcareAcademic Publishing and Open Access

Cited by 227

Automation Bias and Assistive AI: Risk of Harm From AI-Driven Clinical Decision Support

Khera, R., Simon, M. A., & Ross, J. S. (2023) · JAMA

Artificial Intelligence in Healthcare and EducationHuman-Automation Interaction and Safety

Cited by 222

Influence of Patients' Socioeconomic Status on Clinical Management Decisions: A Qualitative Study

Bernheim, S. M., Ross, J. S., Krumholz, H. M., & Bradley, E. H. (2008) · The Annals of Family Medicine

Health disparities and outcomesPublic Health and Social Inequalities

Cited by 212

AI, Health, and Health Care Today and Tomorrow: The JAMA Summit Report on Artificial Intelligence

Angus, D. C., Khera, R., Lieu, T., Liu, V., Ahmad, F. S., Anderson, B., Bhavani, S. V., Bindman, A., Brennan, T., Celi, L. A., et al. (2025) · JAMA

Artificial Intelligence in Healthcare and EducationEthics and Social Impacts of AI

Cited by 195

Retracted papers originating from paper mills: cross sectional study

Candal-Pedreira, C., Ross, J. S., Ruano-Ravina, A., Egilman, D. S., Fernández, E., & Pérez-Ríos, M. (2022) · BMJ

Academic integrity and plagiarismscientometrics and bibliometrics research

Cited by 156

Intensive treatment and severe hypoglycemia among adults with type 2 diabetes

McCoy, R. G., Lipska, K. J., Yao, X., Ross, J. S., Montori, V. M., & Shah, N. D. (2016) · JAMA Internal Medicine

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 143

Adoption of New Glucose-Lowering Medications in the U.S.—The Case of SGLT2 Inhibitors: Nationwide Cohort Study

McCoy, R. G., Dykhoff, H. J., Sangaralingham, L., Ross, J. S., Karaca-Mandic, P., Montori, V. M., & Shah, N. D. (2019) · Diabetes Technology & Therapeutics

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 122

Time to publication among completed clinical trials

Ross, J. S., Mocanu, M., Lampropulos, J. F., Tse, T., & Krumholz, H. M. (2013) · JAMA Internal Medicine

Academic Publishing and Open AccessMeta-analysis and systematic reviews

Cited by 114

The Importance of Clinical Trial Data Sharing: Toward More Open Science

Ross, J. S., Lehman, R., & Gross, C. P. (2012) · Circulation: Cardiovascular Quality and Outcomes

Research Data Management PracticesEthics in Clinical Research

Cited by 104

Levothyroxine Use in the United States, 2008-2018

Brito, J. P., Ross, J. S., El Kawkgi, O. M., Maraka, S., Deng, Y., Shah, N. D., & Lipska, K. J. (2021) · JAMA Internal Medicine

Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery

Cited by 94

Second-Line Therapy for Type 2 Diabetes Management: The Treatment/Benefit Paradox of Cardiovascular and Kidney Comorbidities

McCoy, R. G., Van Houten, H. K., Karaca-Mandic, P., Ross, J. S., Montori, V. M., & Shah, N. D. (2021) · Diabetes Care

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 57

Compliance with prospective trial registration guidance remained low in high-impact journals and has implications for primary end point reporting

Dal-Ré, R., Ross, J. S., & Marušić, A. (2016) · Journal of Clinical Epidemiology

Meta-analysis and systematic reviewsAcademic Publishing and Open Access

Cited by 55

Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes

Khera, R., Aminorroaya, A., Dhingra, L. S., Thangaraj, P. M., Pedroso Camargos, A., Bu, F., Ding, X., Nishimura, A., Anand, T. V., Arshad, F., et al. (2024) · Journal of the American College of Cardiology

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 47

Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM Study

Khera, R., Aminorroaya, A., Dhingra, L. S., Thangaraj, P. M., Camargos, A. P., Bu, F., Ding, X., Nishimura, A., Anand, T. V., Arshad, F., et al. (2024) · Journal of the American College of Cardiology

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 46

Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study

Zou, C. X., Becker, J. E., Phillips, A. T., Garritano, J. M., Krumholz, H. M., Miller, J. E., & Ross, J. S. (2018) · Trials

Pharmaceutical industry and healthcareMeta-analysis and systematic reviews

Cited by 36

Ransomware Attacks and Data Breaches in US Health Care Systems

Jiang, J. X., Ross, J. S., & Bai, G. (2025) · JAMA Network Open

Thoreau and American LiteratureInformation and Cyber Security

Cited by 35